Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eculizumab in Adolescent Patients With Refractory Generalized Myasthenia Gravis: A Phase 3, Open-Label, Multicenter Study.

Pediatric neurology·2024
Same author

Continued safety and long-term effectiveness of onasemnogene abeparvovec in Ohio.

Neuromuscular disorders : NMD·2023
Same author

Powassan Virus Infection Detected by Metagenomic Next-Generation Sequencing, Ohio, USA.

Emerging infectious diseases·2023
Same author

Causes of HyperCKemia in Children: A Retrospective Cohort Study.

Journal of child neurology·2022
Same author

Evidence-based guideline: Neuromuscular ultrasound for the diagnosis of ulnar neuropathy at the elbow.

Muscle & nerve·2021
Same author

Gene Therapy for Spinal Muscular Atrophy: Safety and Early Outcomes.

Pediatrics·2020
Same journal

Join AANEM.

Muscle & nerve·2026
Same journal

Targeted Muscle Reinnervation for Management and Prevention of Symptomatic Neuroma.

Muscle & nerve·2026
Same journal

AANEM News & Insights.

Muscle & nerve·2026
Same journal

Fat-Fraction Quantification Using Three-Point Dixon Technique in Duchenne Muscular Dystrophy and Its Correlation With Clinical Progression and Genotypic Characteristics: A Single Centre One-Year Prospective Study.

Muscle & nerve·2026
Same journal

Characterizing Combined Central and Peripheral Demyelination-Insights From a Multimodal Comparison With Chronic Inflammatory Demyelinating Polyneuropathy and Multiple Sclerosis.

Muscle & nerve·2026
Same journal

Electrical Modalities in the Rehabilitation of Peripheral Nerve Injuries: State of the Literature and Current Clinical Applications.

Muscle & nerve·2026
See all related articles

Related Experiment Video

Updated: May 14, 2026

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
10:02

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy

Published on: November 3, 2016

Pediatric Guillain-Barré Syndrome.

Matthew Ginsberg1

  • 1Division of Neurology, Akron Children's Hospital, Akron, Ohio, USA.

Muscle & Nerve
|May 13, 2026
PubMed
Summary
This summary is machine-generated.

Guillain-Barré syndrome (GBS) in children presents uniquely, often with nonspecific symptoms delaying diagnosis. Early recognition of these pediatric-specific features is crucial for effective management and favorable outcomes.

Keywords:
GBSGuillain–Barré syndromeneuropathypediatricradiculopathy

More Related Videos

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

Related Experiment Videos

Last Updated: May 14, 2026

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
10:02

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy

Published on: November 3, 2016

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

Area of Science:

  • Pediatric Neurology
  • Neuroimmunology

Background:

  • Guillain-Barré syndrome (GBS) is a primary cause of acute flaccid paralysis in children.
  • Pediatric GBS exhibits distinct clinical features compared to adult GBS, impacting diagnosis and management.

Purpose of the Study:

  • To highlight the pediatric-specific nuances of GBS presentation, diagnosis, and management.
  • To emphasize the importance of recognizing atypical symptoms and diagnostic challenges in children.

Main Methods:

  • Review of clinical features, diagnostic approaches, and treatment strategies for pediatric GBS.
  • Comparison of pediatric GBS with adult GBS and other potential etiologies.

Main Results:

  • Pediatric GBS often presents with nonspecific symptoms like pain or irritability preceding weakness, leading to diagnostic delays.
  • Diagnostic evaluations in children can be challenging, sometimes requiring sedation for procedures like electrodiagnostic testing or lumbar puncture.
  • Spinal MRI with gadolinium can aid diagnosis and rule out other conditions. Intravenous immunoglobulin is the primary treatment, with plasma exchange used less frequently.

Conclusions:

  • Timely diagnosis and management of pediatric GBS require awareness of its unique presentation and diagnostic hurdles.
  • While outcomes are generally good, disease severity and supportive care influence prognosis.
  • Acute-onset chronic inflammatory demyelinating polyradiculoneuropathy is a key differential diagnosis requiring longitudinal assessment.